Xiaoping Jiang

FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1

Joohee Sul, Gideon M. Blumenthal, Xiaoping Jiang et al. · The Oncologist · 2016 · 360 citations · Full text

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

Michael H. Brave, Vicki Goodman, Edvardas Kaminskas et al. · Clinical Cancer Research · 2008 · 239 citations

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations

Lauretta Odogwu, Luckson Mathieu, Gideon M. Blumenthal et al. · The Oncologist · 2018 · 212 citations · Full text

U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma

Michael D. Axelson, Ke Liu, Xiaoping Jiang et al. · Clinical Cancer Research · 2013 · 182 citations · Full text

Regulatory Considerations, U.s. Food, Medicine +12

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 170 citations